Tocilizumab as a promising agent against COVID-19: Issues and challenges
Main Authors: | Farzaneh Dastan, Payam Tabarsi, Atefeh Abedini, Ali Saffaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Research in Medical Sciences |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=80;epage=80;aulast=Dastan |
Similar Items
-
Potential therapeutic effects of pentoxifylline against COVID-19
by: Atefeh Abedini, et al.
Published: (2020-01-01) -
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
by: Farzaneh Dastan, et al.
Published: (2020-06-01) -
Promising novel treatment against keloids: Antivascular endothelial growth factor agents
by: Bahareh Abtahi-Naeini, et al.
Published: (2019-01-01) -
Tocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia
by: Sameer Bansal, et al.
Published: (2021-01-01) -
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung
by: Farzaneh Dastan, et al.
Published: (2020-05-01)